MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

506163

Report Date :

04.05.2018

 

 

IDENTIFICATION DETAILS

 

Name :

DRUSHTVO ZA FARMACEVTSKO HEMISKI PROIZVODI REPLEK FARM DOOEL SKOPJE

 

 

Registered Office :

Kozle 188, 1000 Skopje

 

 

Country :

Macedonia

 

 

Financials (as on) :

December 2016

 

 

Date of Incorporation :

21.02.2001

 

 

Com. Reg. No.:

MK4030001411927

 

 

Legal Form :

Limited liability company 

 

 

Line of Business :

Manufacture of basic pharmaceutical products

 

 

No. of Employees :

285

 


 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

EUR 100.000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

Macedonia

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

MACEDONIA - ECONOMIC OVERVIEW

 

Since its independence in 1991, Macedonia has made progress in liberalizing its economy and improving its business environment. Its low tax rates and free economic zones have helped to attract foreign investment, which is still low relative to the rest of Europe. Corruption and weak rule of law remain significant problems. Some businesses complain of opaque regulations and unequal enforcement of the law.

Macedonia’s economy is closely linked to Europe as a customer for exports and source of investment, and has suffered as a result of prolonged weakness in the euro zone. Unemployment has remained consistently high at about 23%, but may be overstated based on the existence of an extensive gray market, estimated to be between 20% and 45% of GDP, which is not captured by official statistics.

Macedonia is working to build a country-wide natural gas pipeline and distribution network. Currently, Macedonia receives its small natural gas supplies from Russia via Bulgaria. In 2016, Macedonia signed a memorandum of understanding with Greece to build an interconnector that could connect to the Trans Adriatic Pipeline that will traverse the region once complete, or to an LNG import terminal in Greece.

Macedonia maintained macroeconomic stability through the global financial crisis by conducting prudent monetary policy, which keeps the domestic currency pegged to the euro, and inflation at a low level. However, in the last two years, the internal political crisis has hampered economic performance, with GDP growth slowing in 2016 and 2017, and both domestic private and public investments declining. Fiscal policies were lax, with unproductive public expenditures, including subsidies and pension increases, and rising guarantees for the debt of state owned enterprises, and fiscal targets were consistently missed. In 2017, public debt stabilized at about 47% of GDP, still relatively low compared to its Western Balkan neighbors and the rest of Europe.

 

Source : CIA

 


 Contact information

 

Company name

Drushtvo za farmacevtsko hemiski proizvodi REPLEK FARM DOOEL Skopje

Trading name

REPLEK FARM

REPLEK FARM LTD

Registered address

Kozle 188, 1000 Skopje

Correspondence address

Kozle 188, 1000 Skopje

Telephone number

+389 23081350

Fax number

+389 23081352

Email address

info@replek.com.mk

Website

www.replek.com.mk

 

 

Registration

 

Registration number

MK4030001411927

VAT-number

MK4030001411927

Status

Active

Establishment date

21-02-2001

Legal form

Limited liability company 

Subscribed share capital

EUR 10.929.719

 

 

Activities

 

Manufacture of basic pharmaceutical products.

 

 

Relations

           

Shareholders

Drushtvo za medicinsko snabduvanje uvoz-izvoz REPLEK AD Skopje

Structure

Subsidiaries/participations:

None on record

Branches

No branches on record

 

 

Management

 

Name

TUDJAROV Ivan

Postition

Director

 

Employees

 

Year

2017

 

 

 

 

 

285

 

 

 

 

 

 

Credit limit

 

Credit limit

EUR 100.000

 

 

Bank

           

Stopanska Banka AD Skopje

 

 

Payments

 

No negative information.

 

 

Remarks

 

Auditor:

 

Import: Austria, Germany, Serbia

 

 

Finances

 

Profit & Loss

Financial Year

12/2016

12/2015

12/2014

Number of Weeks

52

52

52

Currency

EUR

EUR

EUR

Revenue

10,395,891

9,972,932

9,250,453

Operating Profit

1,690,893

1,706,644

1,192,687

Profit before Tax

3,291,399

3,251,207

2,188,878

Tax

147,097

180,579

144,099

Profit after Tax

1,498,602

1,445,024

950,340

 

 

Balance Sheet

 

Financial Year

12/2016

12/2015

12/2014

Number of Weeks

52

52

52

Currency

EUR

EUR

EUR

Total Tangible Assets

12,167,756

11,665,628

10,850,264

Total Intangible Assets

180,088

183,108

186,354

Total Other Fixed Assets

-

-

-

TOTAL FIXED ASSETS

12,347,844

11,848,736

11,036,618

Total Inventories

2,052,699

1,328,627

1,756,809

Total Receivables

3,950,094

3,454,601

3,508,116

Other Current Assets

2,603,653

2,672,460

2,227,396

TOTAL CURRENT ASSETS

-

-

-

TOTAL ASSETS

20,954,290

19,304,424

18,528,939

TOTAL CURRENT LIABILITIES

4,523,781

4,011,551

3,864,193

TOTAL LONG TERM LIABILITIES

166,700

-

234,039

TOTAL LIABILITIES

-

-

-

Called Up Share Capital

10,892,012

10,790,705

10,462,896

Other Reserves

5,355,905

4,496,929

3,953,983

TOTAL SHAREHOLDERS EQUITY

16,247,917

15,287,634

14,416,879

 

Other Financials

Financial Year

12/2016

12/2015

12/2014

Working Capital

-

-

-

Net Worth

16,067,830

15,104,526

14,230,525

 

Ratios

Financial Year

12/2016

12/2015

12/2014

Pre-Tax Profit Margin (%)

31.66 %

32.60 %

23.66 %

Return On Capital Employed (%)

20.05 %

21.27 %

14.94 %

Return On Total Assets Employed (%)

15.71 %

16.84 %

11.81 %

Return On Net Assets Employed (%)

20.26 %

21.27 %

15.18 %

Sales/Net Working Capital

-

-

-

Stock Turnover Ratio (%)

19.75 %

13.32 %

18.99 %

Debtor Days

-

-

-

Creditor Days

-

-

-

Current Ratio

-

-

-

Liquidity Ratio/Acid Test

-

-

-

Current Debt Ratio

0.28

0.26

0.27

Gearing (%)

-

-

-

Equity In Percentage (%)

78.21 %

79.95 %

78.60 %

Total Debt Ratio

-

-

-

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

INR 66.61

UK Pound

1

INR 90.60

Euro

1

INR 79.86

MKD

1

INR 1.30

 

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

PRI

 

 

Report Prepared by :

KET

                                                


 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.